Shares of French biotech company Innate Pharma SA were on the rise on Thursday in premarket trading. The stock gained 23% after Wall Street learned that the European Medicines Agency had accepted the company’s application for leukemia treatment Lumoxiti. A late-stage clinical trial presented at ASH 2019, revealed that 36% of patients with relapsed or … Continue reading “Innate Pharma Explodes on Leukemia Drug Submission in Europe”
Biotech & Pharma
Pulmatrix Inc. Scores Licensing Agreement with Johnson & Johnson
Clinical stage biopharmaceutical company Pulmatrix has announced a licensing agreement with Johnson & Johnson this…
Spectrum Pharmaceuticals Sees its Worst Day in 17 Years
Biopharma company Spectrum Pharmaceuticals were crashing on Thursday after the company said a mid-stage trial…
Sarepta Therapeutics Announces Partnership With Roche to Sell Key Gene Therapy
Shares of Sarepta Therapeutics were gaining this week after Wall Street learned that the company…
The FDA Suddenly Approves This Drug From Sarepta Therapeutics
Shares of Sarepta Therapeutics were on the rise after the Food and Drug Administration (FDA)…
Sorrento Therapeutics Turns Down Unsolicited Offer
Shares of Sorrento Therapeutics were pulling back after almost doubling this week on reports that…
Global Blood Lands FDA Approval for Pill to Treat Sickle Cell Disease
Shares of Global Blood were jumping over 10% this week on news that the company…
Shares of La Jolla Pharmaceutical Company Crash As CEO Departs
Shares of La Jolla Pharmaceutical were nosediving on Monday in pre-market trading after Wall Street…
Amarin Shares Explode Ahead of FDA Decision
Shares of Amarin climbed higher on Tuesday ahead of an FDA meeting for the company's…
Agile Therapeutics Shares Explode as Contraceptive Patch Twirla Gets Nod from FDA
Agile Therapeutics shares were on the rise this week, rocketing nearly 300% after the women's…
Biogen Surprises Wall Street With This News
Biogen announced on Tuesday that its Alzheimer's treatment was ready to start the regulatory approval…
Reata Pharmaceuticals Explodes as Company Meets Study Endpoint
Shares of Reata Pharmaceuticals were popping on Monday in after-hours trading as Wall Street learned…
Akcea Therapeutics Soars on Licensing Agreement with Pfizer
Shares of Akcea Therapeutics were exploding on Monday after the company revealed that it had…
Drugstores Are Suspending Sales of Heartburn Medicine Zantac Due to This Health Concern
Walgreens just became the latest retailer to suspend sales of Zantac, a heartburn medicine from…